We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
-2.74%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.12B
AUM Growth
-$453M
Cap. Flow
-$364M
Cap. Flow %
-17.13%
Top 10 Hldgs %
34.33%
Holding
91
New
7
Increased
22
Reduced
20
Closed
19

Top Buys

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$27.3M
2
VEEV icon
Veeva Systems
VEEV
+$16.4M
3
IMGN
Immunogen Inc
IMGN
+$14.5M
4
DAWN
Day One Biopharmaceuticals
DAWN
+$14.1M
5
TSBX
Turnstone Biologics
TSBX
+$13.6M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$112M
2
PEN icon
Penumbra
PEN
+$46.5M
3
SYK icon
Stryker
SYK
+$35.2M
4
DVAX
Dynavax Technologies
DVAX
+$34.9M
5
UHS icon
Universal Health Services
UHS
+$26.3M

Sector Composition

Rank Sector Weight
1 Healthcare 96.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THC icon
26
Tenet Healthcare
THC
$20.1B
$38.1M 1.8%
578,704
+67,310
+13% +$5.03M
AXSM icon
27
Axsome Therapeutics
AXSM
$10.9B
$36.6M 1.72%
523,210
+27,628
+6% +$2.07M
ALKS icon
28
Alkermes
ALKS
$8.31B
$32.5M 1.53%
1,162,030
+10,646
+0.9% +$312K
CRBU icon
29
Caribou Biosciences
CRBU
$149M
$32.1M 1.51%
6,724,715
+1,153,846
+21% +$7.16M
TMO icon
30
Thermo Fisher Scientific
TMO
$213B
$31.5M 1.48%
62,143
– –
SRPT icon
31
Sarepta Therapeutics
SRPT
$1.68B
$30.4M 1.43%
250,967
+85,202
+51% +$9.63M
DXCM icon
32
DexCom
DXCM
$32.9B
$29.7M 1.4%
318,769
-55,709
-15% -$6.28M
HCA icon
33
HCA Healthcare
HCA
$88B
$29.4M 1.39%
119,535
-39,237
-25% -$10.7M
DAWN
34
DELISTED
Day One Biopharmaceuticals
DAWN
$27.3M 1.29%
2,224,598
+1,077,458
+94% +$14.1M
ACHC icon
35
Acadia Healthcare
ACHC
$2.85B
$26.6M 1.25%
377,869
-3,433
-0.9% -$257K
LNTH icon
36
Lantheus
LNTH
$6.59B
$25.9M 1.22%
+372,761
New +$27.3M
RCUS icon
37
Arcus Biosciences
RCUS
$3.47B
$25.2M 1.19%
1,405,056
– –
VEEV icon
38
Veeva Systems
VEEV
$33.5B
$24.2M 1.14%
118,905
+81,484
+218% +$16.4M
KRTX
39
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$23.4M 1.1%
138,209
– –
BMRN icon
40
CALL
BioMarin Pharmaceuticals
BMRN
$11.6B
$18.9M 0.89%
+213,100
New +$19M
BLUE
41
DELISTED
bluebird bio
BLUE
$18.4M 0.87%
302,047
-62,209
-17% -$4.37M
IMVT icon
42
Immunovant
IMVT
$7.91B
$18.1M 0.85%
472,540
+83,622
+22% +$1.89M
PRAX icon
43
Praxis Precision Medicines
PRAX
$8.52B
$15.3M 0.72%
594,666
+1,882
+0.3% +$35.6K
ROIV icon
44
Roivant Sciences
ROIV
$24.1B
$14.2M 0.67%
1,215,033
+830,042
+216% +$9.38M
IMGN
45
DELISTED
Immunogen Inc
IMGN
$13.8M 0.65%
+869,889
New +$14.5M
NARI
46
PUT
DELISTED
Inari Medical, Inc. Common Stock
NARI
$13.1M 0.62%
+200,000
New +$12.6M
EPIX
47
DELISTED
ESSA Pharma
EPIX
$13M 0.61%
4,199,253
-5,700
-0.1% -$16.4K
UHS icon
48
Universal Health Services
UHS
$10.2B
$11.4M 0.54%
90,509
-192,748
-68% -$26.3M
AKRO
49
DELISTED
Akero Therapeutics
AKRO
$10.8M 0.51%
+214,298
New +$9.98M
PNT
50
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$10.8M 0.51%
1,613,516
+314,025
+24% +$2.61M
1
2
3 4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return

PFM Health Sciences's Q3 2023 Portfolio in Review

As of Q3 2023, PFM Health Sciences held 91 positions worth $2.12B, down 18% from $2.58B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

PFM Health Sciences withdrew a net $364M in Q3 2023, closing 19 positions and reducing 20 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $112M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 95% a quarter earlier.

Against the trend, PFM Health Sciences opened a new position in Lantheus worth $25.9M.

  • PFM Health Sciences's largest Q3 2023 buy was Lantheus: 372,761 shares worth $25.9M.
  • PFM Health Sciences added most to Veeva Systems in Q3 2023, an estimated $16.4M increase.
  • PFM Health Sciences's biggest Q3 2023 reduction was Penumbra, cutting an estimated $46.5M.
  • PFM Health Sciences fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2023, selling an estimated $112M.
  • PFM Health Sciences's ten largest holdings make up 34% of its $2.12B portfolio in Q3 2023.
  • PFM Health Sciences opened 7 new positions and closed 19 in Q3 2023.
  • PFM Health Sciences's portfolio value fell 18% quarter-over-quarter to $2.12B.

Based on PFM Health Sciences's 13F filing for Q3 2023, filed 14 Nov 2023.